Viewing Study NCT01135212


Ignite Creation Date: 2025-12-26 @ 10:46 PM
Ignite Modification Date: 2025-12-26 @ 10:46 PM
Study NCT ID: NCT01135212
Status: COMPLETED
Last Update Posted: 2012-08-24
First Post: 2010-05-31
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension
Sponsor: Boryung Pharmaceutical Co., Ltd
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A657-BR-CT-302
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View